Laboratory Parameters of Hemostasis, Adhesion Molecules, and Inflammation in Type 2 Diabetes Mellitus: Correlation with Glycemic Control

Autor: Rossella Cimino, Salvatore A. Pullano, Eleonora Palella, Daniela Foti, Elio Gulletta, Antonino S. Fiorillo, Antonio Brunetti, Marta Greco
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Blood Glucose
Male
endocrine system diseases
type 2 diabetes mellitus
Health
Toxicology and Mutagenesis

lcsh:Medicine
030204 cardiovascular system & hematology
Gastroenterology
Cohort Studies
chemistry.chemical_compound
0302 clinical medicine
adhesion molecules
medicine.diagnostic_test
Cell adhesion molecule
Middle Aged
Intercellular Adhesion Molecule-1
P-Selectin
Cardiovascular Diseases
Female
E-Selectin
Selectin
Partial thromboplastin time
Adult
medicine.medical_specialty
Vascular Cell Adhesion Molecule-1
030209 endocrinology & metabolism
Article
03 medical and health sciences
Internal medicine
Plasminogen Activator Inhibitor 1
medicine
Humans
prothrombotic risk
Glycemic
Prothrombin time
Glycated Hemoglobin
business.industry
lcsh:R
Public Health
Environmental and Occupational Health

nutritional and metabolic diseases
chemistry
Diabetes Mellitus
Type 2

Glycemic Index
inflammation
Hemostasis
hemostasis
Glycated hemoglobin
business
Cell Adhesion Molecules
Biomarkers
Zdroj: International Journal of Environmental Research and Public Health
Volume 17
Issue 1
International Journal of Environmental Research and Public Health, Vol 17, Iss 1, p 300 (2020)
ISSN: 1660-4601
DOI: 10.3390/ijerph17010300
Popis: Background: Type 2 diabetes mellitus (T2DM) is characterized by a prothrombotic state, predisposing to vascular complications. Some related markers, linking thrombophilia to hemostasis and inflammation, however, have been poorly explored in relation to patients&rsquo
glycemia. We therefore investigated the association of laboratory hemostatic parameters, circulating adhesion molecules (ADMs), white blood cell (WBC) count, and neutrophil/lymphocyte ratio (NLR) with T2DM and glycemic control. Research design: In this study, 82 subjects, grouped into T2DM patients (n = 41) and healthy individuals (n = 41) were enrolled. To evaluate glycemic control, the T2DM cohort was expanded to 133 patients and sub-classified according to glycated hemoglobin (HbA1c) <
7% and &ge
7% (n = 58 and n = 75, respectively). We assessed glycemia, HbA1c, prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen, plasminogen activator inhibitor-1 (PAI-1), platelet and leukocyte parameters, vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), and selectins (E-, P-, L-). Results: PT % activity, PAI-1, VCAM-1, WBC, and neutrophil counts were significantly higher in T2DM patients than in healthy subjects. Poor glycemic control (HbA1c &ge
7%) was correlated with increased PT activity (p = 0.015), and higher levels of E-selectin (p = 0.009), P-selectin (p = 0.012), and NLR (p = 0.019). Conclusions: Both T2DM and poor glycemic control affect some parameters of hemostasis, inflammation, and adhesion molecules. Further studies are needed to establish their clinical utility as adjuvant markers for cardio-vascular risk in T2DM patients.
Databáze: OpenAIRE